ACR GUIDELINES Bundle (free trial)

Kawasaki Disease

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512424

Contents of this Issue

Navigation

Page 2 of 5

vessel vasculitis, one of two primary predominantly affect children purpura/IgA vasculitis). years of age with an incidence in the US of diabetes. a low rate of mortality (approximately 0.08% most common cause of acquired cardiac and 5% of treated cases developing coronary of a coronary artery aneurysm is 50% even in immunoglobulin (IVIG) within the first 10 days of guidance regarding diagnostic strategies, role of echocardiography for patients Definitions and Medications Table 1. Definitions for Selected Terms Used in the Recommendations for KD Term Definition A. Disease states KD Fever lasting at least five days without any other explanation with at least four of the five following principal clinical findings: • Bilateral bulbar conjunctival injection without exudate • Erythema and cracking of lips, strawberry tongue, and/or erythema of oral and pharyngeal mucosa • Erythema and edema of the hands or feet (acute phase), and/or periungual desquamation (subacute phase) • Maculopapular, diffuse erythroderma, or erythema multiforme-like rash • Cervical lymphadenopathy (at least one lymph node >1.5 cm in diameter), usually unilateral e diagnosis may be made with only 4 days of fever if ≥4 principal clinical findings are present. Incomplete KD Prolonged unexplained fever in an infant or child with <4 of the principal clinical findings of KD (see above), and compatible laboratory studies (elevated erythrocyte sedimentation rate [ESR]/ C-reactive protein [CRP], elevated transaminases, urinalysis [UA] with leukocyte esterase negative white blood cell [WBC]) or echocardiographic findings (coronary artery dilatation). a Acute KD Initial febrile phase of KD. B. Medications IVIG Single dose of 2 g/kg (no defined maximum dose, however reasonable maximum ranges are 100–140 g ). Glucocorticoids (GC) Prednisone 2 mg/kg/day (maximum dose 60 mg/day) for 15 days, or equivalent. Non-GC immunomodulatory therapy Anakinra, cyclosporine, or infliximab. Aspirin High dose: 80-100 mg/kg/day. Moderate dose: 30–50 mg/kg/day. Low dose: 3–5 mg/kg/day. a Defined according to algorithm in Burns, J.C. Pediatrics, 2010. 125(2): p. E234–E241 and McCrindle, B.W., et al. Circulation, 2017. 135(17): p. e927–e999.

Articles in this issue

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - Kawasaki Disease